Skip to content

Creating an EMR to EDC Pipeline through eSource

Date: June 2022

The CRIO Innovation Theater: Creating an EMR to EDC pipeline through eSource, presented insights to a jam-packed audience at DIA’s 2022 Global Annual Meeting. In case you missed it, view the recording right here, courtesy of DIA.

Overview

EMR-to-EDC integration is challenging to scale due to the fragmentation of health care providers. With EMR interoperability, patients have the power to collect their own medical records and direct them into e-clinical platforms. CRIO and Pluto Health Health will demonstrate a groundbreaking innovation whereby Pluto Health Health aggregates medical records on behalf of patients and sends them to CRIO’s integrated eSource-to-EDC platform, thus creating the industry’s first truly scalable EMR-to-EDC pipeline.

Panelists: 

  • Dr. Elena Christofides, CEO at Endocrinology Associates Inc.
  • Raymond Nomizu, CEO and co-founder at CRIO
  • Dr. Seung Park, Head of Medical Informatics at Pluto Health

Schedule a demo to discover more.

CRIO favicon by Team CRIO
Share this post
You may also find interesting
Explore our Blog
Monitors Favor CRIO Over Paper By 3:1 Margins
Videos

Monitors Favor CRIO Over Paper By 3:1 Margins

One CRA discovered the benefits of the CRIO system and introduced it to other sites on a trial. The CRAs’ favorable impressions were confirmed in a subsequent survey of CRA users of the CRIO eSource/EDC system, who favored CRIO over paper on promoting data integrity, compliance and rigorous QC by 3:1 margins. Schedule a demo...

Faster, Better, Cheaper Clinical Trials Using CRIO
Videos

Faster, Better, Cheaper Clinical Trials Using CRIO

Find out how CRIO Reviewer, an integrated eSource/EDC platform, can help you reduce costs, improve quality, and eliminate costly enrollment delays on your next clinical trial. Our solution eliminates SDV, reduces on-site monitoring time, and increases enrollment rates by eliminating double entry into eSource and EDC systems. Schedule a demo to explore CRIO.